测试者平均大甩60磅 美国糖尿病药减重测试见强效
文章来源: 星岛日报 于
- 新闻取自各大新闻媒体,新闻内容并不代表本网立场!
最新研究发现,治疗糖尿病的药物“蒙扎罗”(Mounjaro)有助超重人士减磅,配合严格节食以及运动之后,平均可减去1/4体重,实际相等于60磅,成效与胃绕道手术相若。
美联社报道,这项研究由蒙扎罗的生产商礼来公司(Eli
Lilly)资助进行,邀请800名体重超标并且健康已出现问题的人士参与,但全部人尚未患上糖尿病,各人开始实验时平均体重241磅,BMI指数约38。
根据流程,他们首先依靠节食与运动减肥,这个阶段减去7%即17磅体重,之后分成两组,一组注射蒙扎罗,另一组则注射安慰剂,结果发现使用蒙扎罗的人,平均额外再减去44磅,但注射安慰剂的人体重却反弹,比最初体重还要增加6磅。整体而言,88%注射蒙扎罗的人可以减去5%体重,近29%的人可减去至少1/4体重,相比之下注射安慰剂的人,只有1%可减去1/4体重。
这次研究结果已经刊登于《自然医学》(Nature Medicine)期刊。
在最初3个月的节食运动阶段,约有200人因为减肥成绩不理想,或者其他原因退出实验,最后近500人完成为期16个月的研究。副作用方面,注射蒙扎罗的人出现恶心、腹泻、便秘等现象的几率较高,但程度通常介乎轻微至中等,大约10%测试者因此而退出实验。
没有参与这次研究的布莱根妇女医院(Brigham and Women’s Hospital)医生阿波维安(Caroline
Apovian)形容,数据显示蒙扎罗可能是目前减肥效果最明显的药物之一。
蒙扎罗含有针对两种激素的成分“替西帕”(Tirzepatide),于2022年5月获批准,用于治疗糖尿病,而目前市面两种受欢迎的减肥药Ozempic和Wegovy,只能针对一种激素。3款药物都供不应求,民众假如服用的话,每个月的成本都在900元以上。
-->
`,
"script":[]
}
, "gg_rightside": {
"html":`
`,
"script":[{"type":"text/javascript","src":"//widgets.outbrain.com/outbrain.js","async":"async"}]
}
, "gg_duturandom": {
"html":`
`,
"script":[]
}
, "gg_square": {
"html":`
`,
"script":[]
}
, "gg_topbanner": {
"html":`
`,
"script":[]
}
, "gg_middlesquare": {
"html":`
`,
"script":[]
}
, "gg_dutu": {
"html":`
`,
"script":[]
}
, "gg_botline": {
"html":``,
"script":[]
}
, "gg_dututop": {
"html":`
`,
"script":[]
}
, "gg_shipintop": {
"html":`
`,
"script":[]
}
, "gg_inContent": {
"html":`
`,
"script":[]
}
, "gg_shipinrandom": {
"html":``,
"script":[]
}
, "gg_sideSticky": {
"html":`
`,
"script":[]
}
, "gg_bottombanner": {
"html":`
`,
"script":[{"type":"text/javascript","src":"//widgets.outbrain.com/outbrain.js","async":"async"}]
}
, "gg_marquee": {
"html":`
`,
"script":[]
}
}
const adEnv={
"gg_header": {
"html":``,
"script":[{"type":"text/javascript","exec":` var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; var pbjs = pbjs || {}; pbjs.que = pbjs.que || []; `},{"type":"text/javascript","src":"https://adncdnend.azureedge.net/adn-hb/adn.wnx2.js","async":""},{"src":"https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js","async":"","data-ad-client":"ca-pub-7528949385909099"},{"type":"text/javascript","src":"https://adncdnend.azureedge.net/adn-video/WenxuecityPlayer.js","async":"async"}]
}
}
const wxcEnv = {
"base":{
"exe":[],
"src":[
{"src": "/js/jquery.cookie.js"},
{"src": "/js/ui/font.js"},
{"src": "/news/js/recommendednews.js?","defer":"true"},
{"src":"/js/wxcFunc.js"}
]
},
"func":{
"exe":[
'function showMoreComments(){let n = 11;for(let i=0;i
2){dom.hide();}}$("#showallcomment").show();$("#showlesscomment").hide();};',
],
"src":[
{"src":"//count.wenxuecity.com/service/count/script/do.php?type=news&id=125232007&n=0&out=jsval"},
{"src": "/news/js/view.js"},
{"src":"/members/js/md5.js"}
]
}
}
function wxcCode(){
wxcEnv.base.exe.forEach(x=>{
let tag = buildAdcode(x);
document.head.append(tag);
})
wxcEnv.base.src.forEach(src => {
let tag = buildSrc(src)
document.head.append(tag);
});
wxcEnv.func.exe.forEach(x=>{
let tag = buildAdcode(x);
document.body.append(tag);
})
wxcEnv.func.src.forEach(src => {
let tag = buildSrc(src)
document.body.append(tag);
});
}
function adcode(){
let adkey = Object.keys(ads);
adkey.forEach(x=>{
let code = ads[x].html;
let div = document.getElementById(x);
if(div)div.innerHTML = code;
ads[x].script.forEach(s=>{
if(Object.keys(s).indexOf('src')===-1){
let tag = buildAdcode(s.exec);
document.body.append(tag);
}else{
let tag = buildSrc(s);
document.body.append(tag);
}
})
})
}
function baseCode(){
let baseKeys = Object.keys(adEnv);
baseKeys.forEach(x=>{
adEnv[x].script.forEach(s=>{
if(Object.keys(s).indexOf('src')===-1){
let tag = buildAdcode(s.exec);
document.head.append(tag);
}else{
let tag = buildSrc(s);
document.head.append(tag);
}
})
})
}
function buildAdcode(script){
let tag = document.createElement('script');
tag.innerHTML = script;
return tag;
}
function buildSrc(obj){
let keys = Object.keys(obj);
let tag = document.createElement("script");
keys.forEach(key=>{
tag.setAttribute(key, obj[key]);
})
return tag ;
}